CH596210A5 - - Google Patents

Info

Publication number
CH596210A5
CH596210A5 CH1458776A CH1458776A CH596210A5 CH 596210 A5 CH596210 A5 CH 596210A5 CH 1458776 A CH1458776 A CH 1458776A CH 1458776 A CH1458776 A CH 1458776A CH 596210 A5 CH596210 A5 CH 596210A5
Authority
CH
Switzerland
Application number
CH1458776A
Inventor
Gilbert Regnier
Roger Canevari
Jean-Claude Poignant
Michel Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH596210A5 publication Critical patent/CH596210A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
CH1458776A 1975-11-19 1976-11-19 CH596210A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47618/75A GB1544419A (en) 1975-11-19 1975-11-19 Purines and pyrazolo-pyrimidines a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CH596210A5 true CH596210A5 (en:Method) 1978-03-15

Family

ID=10445643

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1458776A CH596210A5 (en:Method) 1975-11-19 1976-11-19

Country Status (21)

Country Link
US (1) US4100286A (en:Method)
JP (1) JPS5265296A (en:Method)
AR (1) AR214186A1 (en:Method)
AU (1) AU508926B2 (en:Method)
BE (1) BE848505A (en:Method)
CA (1) CA1083148A (en:Method)
CH (1) CH596210A5 (en:Method)
DE (1) DE2651789C2 (en:Method)
ES (1) ES453460A1 (en:Method)
FR (1) FR2332020A1 (en:Method)
GB (1) GB1544419A (en:Method)
GR (1) GR61601B (en:Method)
IE (1) IE44078B1 (en:Method)
IL (1) IL50938A (en:Method)
MX (1) MX3904E (en:Method)
NL (1) NL7612894A (en:Method)
NZ (1) NZ182681A (en:Method)
OA (1) OA05485A (en:Method)
PH (1) PH11898A (en:Method)
PT (1) PT65859B (en:Method)
ZA (1) ZA766923B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
FR2699176B1 (fr) * 1992-12-11 1995-03-03 Adir Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
US6107300A (en) * 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
TW200400034A (en) * 2002-05-20 2004-01-01 Bristol Myers Squibb Co Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
US9624215B2 (en) * 2012-10-31 2017-04-18 Toyama Chemical Co., Ltd. Amine derivative or salt thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551428A (en) * 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines

Also Published As

Publication number Publication date
GR61601B (en) 1978-12-02
GB1544419A (en) 1979-04-19
US4100286A (en) 1978-07-11
DE2651789A1 (de) 1977-06-02
BE848505A (fr) 1977-05-18
AU508926B2 (en) 1980-04-17
PT65859A (en) 1976-12-01
FR2332020A1 (fr) 1977-06-17
MX3904E (es) 1981-09-11
ES453460A1 (es) 1977-11-16
FR2332020B1 (en:Method) 1980-10-10
DE2651789C2 (de) 1984-09-13
NZ182681A (en) 1978-07-10
IE44078L (en) 1977-05-19
IL50938A (en) 1980-06-30
AR214186A1 (es) 1979-05-15
OA05485A (fr) 1981-03-31
ZA766923B (en) 1977-10-26
IE44078B1 (en) 1981-08-12
JPS5265296A (en) 1977-05-30
PT65859B (en) 1978-05-17
JPS5439396B2 (en:Method) 1979-11-27
PH11898A (en) 1978-08-29
AU1975776A (en) 1978-05-25
NL7612894A (nl) 1977-05-23
CA1083148A (fr) 1980-08-05

Similar Documents

Publication Publication Date Title
JPS5439396B2 (en:Method)
JPS5245648U (en:Method)
CH602508A5 (en:Method)
CH602935A5 (en:Method)
BG20847A1 (en:Method)
BG21347A1 (en:Method)
BG22474A1 (en:Method)
BG22964A1 (en:Method)
CH586864A5 (en:Method)
CH586897A5 (en:Method)
CH587314A5 (en:Method)
CH587374A5 (en:Method)
CH588169A5 (en:Method)
CH588410A5 (en:Method)
CH588716A5 (en:Method)
CH589513A5 (en:Method)
CH592977A5 (en:Method)
CH593052A5 (en:Method)
CH593444A5 (en:Method)
CH594093A5 (en:Method)
CH594804A5 (en:Method)
CH595176A5 (en:Method)
CH595892A5 (en:Method)
CH596036A5 (en:Method)
CH596627A5 (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased